• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number PFO OCCLUDER
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 01/25/2023
Event Type  Injury  
Event Description
Crd_806 - pfo occluder pas, patient site id: (b)(6).It was reported that on (b)(6) 2023, a 35mm pfo occluder was implanted into a patient using a 9f amplatzer trevisio intravascular delivery system.The patients act level was 293 seconds during the procedure.After the procedure, prior to being transferred to recovery, the patient started becoming hypotensive.Echocardiogram revealed a pericardial effusion.The pericardial effusion progressed into a cardiac tamponade.Protomine was administered and act decreased to 107 seconds.Pericardiocentesis performed.The patient was reported to be discharged on (b)(6) 2023.No additional information was provided.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
An event of pericardial effusion and cardiac tamponade was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16390230
MDR Text Key309757147
Report Number2135147-2023-00553
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806011301
UDI-Public00811806011301
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPFO OCCLUDER
Device Catalogue Number9-PFO-035
Device Lot Number8125814
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/25/2023
Initial Date FDA Received02/16/2023
Supplement Dates Manufacturer Received04/13/2023
Supplement Dates FDA Received04/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/07/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AMPLATZER TREVISIO INTRAVASCULAR DELIVERY SYSTEM.
Patient Outcome(s) Required Intervention; Life Threatening;
Patient Age51 YR
Patient SexMale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-